OBJECTIVES: Both dimethylarginines are widely bound to chronic kidney disease (CKD). This study was focused to validate published LC-MS/MS method and compared the measured data with an immunoassay. DESIGN AND METHODS: The analysis was performed on a Dionex UltiMate 3000 UHPLC-Standard (Thermo Fisher Scientific, Waltham, Massachusetts, USA) with an amaZon SL ion trap (Bruker, Billerica, Massachusetts, USA). Comparison was evaluated by using Passing Bablok regression and Bland Altman plot. Healthy volunteers (n = 40) were used for validation and as control group to patients group (n = 40) with different stages of CKD. RESULTS: The results in healthy controls determined by the LC-MS/MS (ELISA) method were 0.52 ± 0.0892 with 95 % CI: 0.49-0.55 (0.61 ± 0.1213 with 95 % CI: 0.57-0.64) μmol/L for AD MA and 0.56 ± 0.0810 with 95 % CI: 0.53-0.58 (0.62 ± 0.0752 with 95 % CI: 0.57-0.65) μmol/L for SDMA. In the same way, the patient group values determined by the LC-MS/MS (ELISA) method were 0.82 ± 0.1604 with 95 % CI: 0.75-0.88 (1.06 ± 0.3002 with 95 % CI: 0.94-1.19) μmol/L and 2.14 ± 0.8778 with 95 % CI: 1.47-2.58 (1.65 ± 0.5160 with 95 % CI: 1.40-1.98) μmol/L for ADMA and SDMA, respectively. The correlation between the methods, expressed as the Spearman correlation coefficient (R), was 0.858 (0.8059) for ADMA (p < 0.0001) and 0.895 (0.9607) for SDMA (p < 0.0001). CONCLUSIONS: ADMA levels determined by the immunoassay were almost 30 % overestimated, in contrast to SDMA levels, which were 3 % underestimated. According to our findings, a better correlation could be obtained by simple sample dilution.

Biomedical Center Faculty of Medicine in Pilsen Charles University Alej Svobody 1655 76 Pilsen 32300 Czech Republic

Department of Clinical Biochemistry and Haematology Charles University and University Hospital Pilsen Czech Republic

See more in PubMed

Tain Y.L., Hsu C.N. Toxic dimethylarginines: asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) Toxins (Basel) 2017;9 doi: 10.3390/toxins9030092. DOI

Papageorgiou N., Androulakis E., Papaioannou S., Antoniades Charalambos, Tousoulis D. Homoarginine in the shadow of asymmetric dimethylarginine: from nitric oxide to cardiovascular disease. Amino Acids. 2017;47:1741–1750. doi: 10.1007/s00726-015-2017-y. PubMed DOI

Lai W.K.C., Kan M.Y. Homocysteine-induced endothelial dysfunction. Ann. Nutr. Metab. 2015;67:1–12. doi: 10.1159/000437098. PubMed DOI

Oliva-Damaso E., Oliva-Damaso N., Rodriguez-Esparragon F., Payan J., Baamonde-Laborda E., Gonzalez-Cabrera F., Santana-Estupiñan R., Rodriguez-Perez J.C. Asymmetric (ADMA) and symmetric (SDMA) dimethylarginines in chronic kidney disease: a clinical approach. Int. J. Mol. Sci. 2019;20 doi: 10.3390/ijms20153668. PubMed DOI PMC

Snauwaert E., Van Biesen W., Raes A., Glorieux G., Van Bogaert V., Van Hoeck K., Coppens M., Roels S., Vande Walle J., Eloot S. Concentrations of representative uraemic toxins in a healthy versus non-dialysis chronic kidney disease paediatric population. Nephrol. Dial. Transplant. 2018;33:978–986. doi: 10.1093/ndt/gfx224. PubMed DOI

Emrich I.E., Zawada A.M., Martens-Lobenhoffer J., Fliser D., Wagenpfeil S., Gunnar ·, Heine H., Bode-Böger S.M. Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease. Clin. Res. Cardiol. 2018;107:201–213. doi: 10.1007/s00392-017-1172-4. PubMed DOI

Rysz J., Gluba-Brzózka A., Franczyk B., Jabłonowski Z., Ciałkowska-Rysz A. Molecular Sciences novel biomarkers in the diagnosis of chronic kidney disease and the prediction of its outcome. Int. J. Mol. Sci. 2017;18:19. doi: 10.3390/ijms18081702. (article number) PubMed DOI PMC

Grassi G., Seravalle G., Trevano F.Q., Spaziani D., Scalise F., Auguadro C., Pizzini P., Tripepi G., D’Arrigo G., Mallamaci F., Mancia G., Zoccali C. Asymmetric and symmetric dimethylarginine and sympathetic nerve traffic after renal denervation in patients with resistant hypertension. Clin. J. Am. Soc. Nephrol. 2015;10:1560–1567. doi: 10.2215/CJN.01220215. PubMed DOI PMC

Lixia Zeng A.V.M., Subramaniam Pennathur J.B. Metabolomic profiling of arginine metabolome links altered methylation to chronic kidney disease accelerated atherosclerosis. J. Proteonomics Bioinf. 2015;s14 doi: 10.4172/jpb.s14-001. PubMed DOI PMC

Schepers E., Barreto D.V., Liabeuf S., Glorieux G., Eloot S., Barreto F.C., Massy Z., Vanholder R. Symmetric dimethylarginine as a proinflammatory agent in chronic kidney disease. Clin. J. Am. Soc. Nephrol. 2011;6:2374–2383. doi: 10.2215/CJN.01720211. PubMed DOI PMC

Schwedhelm E., Maas R., Tan-Andresen J., Schulze F., Riederer U., Böger R.H. High-throughput liquid chromatographic-tandem mass spectrometric determination of arginine and dimethylated arginine derivatives in human and mouse plasma. J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2007;851:211–219. doi: 10.1016/j.jchromb.2006.11.052. PubMed DOI

Krzystek-Korpacka M., Wiśniewski J., Fleszar M.G., Bednarz-Misa I., Bronowicka-Szydełko A., Gacka M., Masłowski L., Kȩdzior K., Witkiewicz W., Gamian A. Metabolites of the Nitric oxide (NO) pathway are altered and indicative of reduced NO and arginine bioavailability in patients with cardiometabolic diseases complicated with chronic wounds of lower extremities: targeted metabolomics approach (LC-MS/MS) Oxid. Med. Cell. Longev. 2019;2019 doi: 10.1155/2019/5965721. PubMed DOI PMC

Boelaert J., Schepers E., Glorieux G., Eloot S., Vanholder R., Lynen F. Determination of asymmetric and symmetric dimethylarginine in serum from patients with chronic kidney disease: UPLC-MS/MS versus ELISA. Toxins (Basel) 2016;8 doi: 10.3390/toxins8050149. PubMed DOI PMC

Maria I., Gangi D., Chiandetti L., Gucciardi A., Moret V., Naturale M., Giordano G. Simultaneous quantitative determination of N G ,N G-dimethyl-l-arginine or asymmetric dimethylarginine and related pathway's metabolites in biological fluids by ultrahigh-performance liquid chromatography/electrospray ionization-tandem mass spectrometry. Anal. Chim. Acta. 2010;677:140–148. doi: 10.1016/j.aca.2010.08.011. PubMed DOI

Martens-Lobenhoffer J., Krug O., Bode-Böger S.M. Determination of arginine and asymmetric dimethylarginine (ADMA) in human plasma by liquid chromatography/mass spectrometry with the isotope dilution technique. J. Mass Spectrom. 2004;39:1287–1294. doi: 10.1002/jms.684. PubMed DOI

Davids M., Swieringa E., Palm F., Smith D.E.C., Smulders Y.M., Scheffer P.G., Blom H.J., Teerlink T. Simultaneous determination of asymmetric and symmetric dimethylarginine, l-monomethylarginine, l-arginine, and l-homoarginine in biological samples using stable isotope dilution liquid chromatography tandem mass spectrometry. J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2012;900:38–47. doi: 10.1016/j.jchromb.2012.05.025. PubMed DOI

Shin S., Fung S.M., Mohan S., Fung H.L. Simultaneous bioanalysis of l-arginine, l-citrulline, and dimethylarginines by LC-MS/MS. J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2011;879:467–474. doi: 10.1016/j.jchromb.2011.01.006. PubMed DOI PMC

D’Apolito O., Paglia G., Tricarico F., Garofalo D., Pilotti A., Lamacchia O., Cignarelli M., Corso G. Development and validation of a fast quantitative method for plasma dimethylarginines analysis using liquid chromatography-tandem mass spectrometry. Clin. Biochem. 2008;41:1391–1395. doi: 10.1016/j.clinbiochem.2008.08.075. PubMed DOI

Teerlink T., Nijveldt R.J., De Jong S., Van Leeuwen P.A.M. Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography. Anal. Biochem. 2002;303:131–137. doi: 10.1006/abio.2001.5575. PubMed DOI

Martens-Lobenhoffer J., Bode-Böger S.M. Quantification of l-arginine, asymmetric dimethylarginine and symmetric dimethylarginine in human plasma: a step improvement in precision by stable isotope dilution mass spectrometry. J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2012;904:140–143. doi: 10.1016/j.jchromb.2012.07.021. PubMed DOI

Arlouskaya Y., Sawicka A., Głowala M., Giebułtowicz J., Korytowska N., Tałałaj M., Nowicka G., Wrzosek M. Asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) concentrations in patients with obesity and the risk of obstructive sleep apnea (OSA) J. Clin. Med. 2019;8:897. doi: 10.3390/jcm8060897. PubMed DOI PMC

Amir M., Hassanein S.I., Rahman M.F.A., Gad M.Z. AGXT2 and DDAH-1 genetic variants are highly correlated with serum ADMA and SDMA levels and with incidence of coronary artery disease in Egyptians. Mol. Biol. Rep. 2018;45:2411–2419. doi: 10.1007/s11033-018-4407-1. PubMed DOI

Lucovnik M., Lackner K., Papousek I., Schmid-Zalaudek K., Schulter G., Roessler A., Moertl M.G. 2017. Hypertension in Pregnancy Systemic Vascular Resistance and Endogenous Inhibitors of Nitric Oxide Synthesis in Early-Compared to Late-Onset Preeclampsia: Preliminary Findings Systemic Vascular Resistance and Endogenous Inhibitors of Nitric Oxide Synthesis. PubMed DOI

Dimitroulas T., Hodson J., Sandoo A., Smith J., Kitas G.D. Endothelial injury in rheumatoid arthritis: a crosstalk between dimethylarginines and systemic inflammation. Arthritis Res. Ther. 2017;19 doi: 10.1186/s13075-017-1232-1. PubMed DOI PMC

Tenderenda-Banasiuk E., Wasilewska A., Taranta-Janusz K., Korzeniecka-Kozerska A. Asymmetric and symmetric dimethylarginine in adolescents with hyperuricemia. Dis. Markers. 2013;35:407–412. doi: 10.1155/2013/267697. PubMed DOI PMC

Pecchini P., Malberti F., Mieth M., Quinn R., Tripepi G., Mallamaci F., Maas R., Zoccali C., Ravani P. Measuring asymmetric dimethylarginine (ADMA) in CKD: a comparison between enzyme-linked immunosorbent assay and liquid chromatographyelectrospray tandem mass spectrometry. J. Nephrol. 2012;25:1016–1022. doi: 10.5301/jn.5000085. PubMed DOI

Schulze F., Wesemann R., Schwedhelm E., Sydow K., Albsmeier J., Cooke J.P., Böger R.H. Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay. Clin. Chem. Lab. Med. 2004;42:1377–1383. doi: 10.1515/CCLM.2004.257. PubMed DOI

J. Martens-Lobenhoffer, S. Westphal, F. Awiszus, S.M. Bode-Böger, C. Luley, Determination of Asymmetric Dimethylarginine: Liq-uid Chromatography-Mass Spectrometry or ELISA?, (n.d.). 10.1373/clinchem.2005.056788.. PubMed DOI

Zinellu A., Sotgia S., Usai M.F., Pintus G., Deiana L., Carru C. Improved method for plasma ADMA, SDMA, and arginine quantification by field-amplified sample injection capillary electrophoresis UV detection. Anal. Bioanal. Chem. 2011;399:1815–1821. doi: 10.1007/s00216-010-4580-0. PubMed DOI

Ivanova M., Artusi C., Boffa G.M., Zaninotto M., Plebani M. HPLC determination of plasma dimethylarginines: method validation and preliminary clinical application. Clin. Chim. Acta. 2010;411:1632–1636. doi: 10.1016/j.cca.2010.06.001. PubMed DOI

Blackwell S., O’Reilly D.S.J., Talwar D.K. HPLC analysis of asymmetric dimethylarginine (ADMA) and related arginine metabolites in human plasma using a novel non-endogenous internal standard. Clin. Chim. Acta. 2009;401:14–19. doi: 10.1016/j.cca.2008.10.032. PubMed DOI

Jones C.E., Darcy C.J., Woodberry T., Anstey N.M., McNeil Y.R. HPLC analysis of asymmetric dimethylarginine, symmetric dimethylarginine, homoarginine and arginine in small plasma volumes using a Gemini-NX column at high pH. J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2009;878:8–12. doi: 10.1016/j.jchromb.2009.10.035. PubMed DOI

Široká R., Trefil L., Rajdl D., Racek J., Cibulka R. Asymmetric dimethylarginine-comparison of HPLC and ELISA methods. J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2007 doi: 10.1016/j.jchromb.2006.12.009. PubMed DOI

Albsmeier J., Schwedhelm E., Schulze F., Kastner M., Böger R.H. Determination of NG,NG-dimethyl-L-arginine, an endogenous NO synthase inhibitor, by gas chromatography-mass spectrometry. J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2004;809:59–65. doi: 10.1016/j.jchromb.2004.06.008. PubMed DOI

Caussé E., Siri N., Arnal J.F., Bayle C., Malatray P., Valdiguié P., Salvayre R., Couderc F. Determination of asymmetrical dimethylarginine by capillary electrophoresis-laser-induced fluorescence. J. Chromatogr. B Biomed. Sci. Appl. 2000;741:77–83. doi: 10.1016/S0378-4347(00)00034-7. PubMed DOI

Martens-Lobenhoffer J., Bode-Böger S.M. Quantification of l-arginine, asymmetric dimethylarginine and symmetric dimethylarginine in human plasma: a step improvement in precision by stable isotope dilution mass spectrometry. J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2012;904:140–143. doi: 10.1016/j.jchromb.2012.07.021. PubMed DOI

Schepers E., Speer T., Bode-Böger S.M., Fliser D., Kielstein J.T. Dimethylarginines ADMA and SDMA: the real water-soluble small toxins? Semin. Nephrol. 2014;34:97–105. doi: 10.1016/j.semnephrol.2014.02.003. PubMed DOI